REVITALIX- medicago sativa l., cinchona officinalis l., ferrosoferric phosphate syrup Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

revitalix- medicago sativa l., cinchona officinalis l., ferrosoferric phosphate syrup

nartex laboratorios homeopati cos, s.a. de c.v. - ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), avena sativa pollen (unii: a7iky24tr7) (avena sativa pollen - unii:a7iky24tr7), cinchona officinalis whole (unii: 3sxm338giq) (cinchona officinalis whole - unii:3sxm338giq) - ferrosoferric phosphate 8 [hp_x] in 240 g - uses:  relieves symptoms such as: - fatigue - physical weakness - loss of strength as per homeopathic materia medica homeopathic medicine nartex labs revitalix alfalfa (medicago sativa l) cinchona (cinchona officinalis l) ferrosoferric phosphate mexican tradition net 8.12 fl oz (240 ml) relieves symptoms such as fatigue physical weakness and loss of strength

FERRIC SUBSULFATE solution Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

ferric subsulfate solution

coopersurgical, inc. - ferric subsulfate (unii: 3qj8ws6v8h) (ferric cation - unii:91o4lml611) - astringyn® is a styptic agent used for achieving local hemostasis. in punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 one method for applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edges of the wound and stretching the skin. the wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension maintained for approximately 15 seconds.2  

Baby Iron Liquid Australija - anglų - Department of Health (Therapeutic Goods Administration)

baby iron liquid

brauer natural medicine pty ltd - ferric pyrophosphate, quantity: 4.5752 mg/ml (equivalent: iron, qty 1.376 mg/ml) - oral liquid - excipient ingredients: malic acid; glycerol; xanthan gum; potassium sorbate; purified water; dextrin; sodium chloride; lecithin; flavour - maintain/support energy levels ; maintain/support healthy growth and development ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support blood health ; helps maintain/support transport of oxygen in the body ; aid/assist/helps oxygen transport to body tissues ; helps maintain/support haemoglobin formation/synthesis ; maintain/support immune system health ; maintain/support healthy immune system function ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support cognitive development ; aid/assist/helps synthesis of neurotransmitters

FERRLECIT Izraelis - anglų - Ministry of Health

ferrlecit

sanofi israel ltd - iron as iron iii sodium ferric glugonate compl. - solution for injection/ concentrate for solution for infusion - iron as iron iii sodium ferric glugonate compl. 62.5 mg / 5 ml - various combinations - various combinations - ferrlecit is indicated in adults and children 6 years and above.severe iron deficiency states only when oral administration has been found impossible; in cases of gastrointestinal malabsorption which rules out oral iron therapy; patients treated by dialysis getting erythropoietin.

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE injection Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

sodium ferric gluconate complex in sucrose injection

hikma pharmaceuticals usa inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. sodium ferric gluconate complex in sucrose injection is contraindicated in patients with known hypersensitivity to sodium ferric gluconate or any of its components. reactions have included anaphylaxis [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions (5.1) ], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant women of the potential risk to the fetus. available data from postmarketing reports with sodium ferric gluconate complex in sucrose injection use in pregnancy are insufficient to assess the risk of major birth defects and miscarriage. sodium ferric gluconate comple

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE injection Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

sodium ferric gluconate complex in sucrose injection

hikma pharmaceuticals usa inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. sodium ferric gluconate complex in sucrose injection is contraindicated in patients with known hypersensitivity to sodium ferric gluconate or any of its components. reactions have included anaphylaxis [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions (5.1) ], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant women of the potential risk to the fetus. available data from postmarketing reports with sodium ferric gluconate complex in sucrose injection use in pregnancy are insufficient to assess the risk of major birth defects and miscarriage. sodium ferric gluconate comple

MONOFERRIC SOLUTION Kanada - anglų - Health Canada

monoferric solution

pharmacosmos a/s - iron (ferric derisomaltose) - solution - 100mg - iron (ferric derisomaltose) 100mg - iron preparations

G-Ferric Injection Bangladešas - anglų - DGDA (Directorate General of Drug Administration)

g-ferric injection

gonoshasthaya pharmaceuticals ltd. - ferric carboxymaltose - injection - 500 mg/10 ml

FERRIC SUBSULFATE Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ferric subsulfate

qpharma pty ltd - ferric subsulphate - unknown - ferric subsulphate mineral-sulfate active 0.0 - active constituent